Device / Technology News

RSS

Sequenom launches iPLEX ADME PGx panel to genotype polymorphisms

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced the launch of its iPLEX ADME PGx panel developed to genotype polymorphisms in genes associated with drug absorption, distribution, metabolism, and excretion (ADME).

4 Oct 2011

Life Technologies, CHEO researcher partner to co-develop microbial detection tests

The Children's Hospital of Eastern Ontario (CHEO) Research Institute is pleased to announce that one of its principal investigators in infectious disease has signed a contract with Life Technologies, an internationally renowned biotech tools company headquartered in Carlsbad, California, to share information that will help to develop tests that uniquely amplify and detect the DNA coding for infectious diseases.

4 Oct 2011

ICREA researcher has set up spin-off Supragen at IRB Barcelona

Roger Gomis, ICREA researcher at the Institute of Research in Biomedicine (IRB Barcelona) has set up the spin-off Supragen. With the support of IRB Barcelona and the Instituci- Catalana de Recerca i Estudis Avan-ats (ICREA), this initiative is the second biotech company to emerge from the institute since June and the third since this centre was set up towards the end of 2005.

4 Oct 2011

New review explores how nanotechnology may develop safer breast implants

A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may be used to develop safer breast implants as an alternative to silicone rubber, minimizing health complications.

4 Oct 2011

Telestroke improves care and reduces costs

The use of long-distance video and data hookups to link remote community hospitals with stroke neurologists in large centres provides the same level of care as having everyone in the same room, according to a new study presented today at the Canadian Stroke Congress.

4 Oct 2011

G&D, Precise Biometrics partner to provide Match-on-Card technology

Precise Biometrics announces that they have entered into a partnership agreement with Giesecke & Devrient (G&D) that will provide Precise Match-on-Card technology for use on G&D smart-cards.

4 Oct 2011

Virtual 18F-FDG PET/CT bronchoscopy may accurately detect NSCLC metastases

For patients with non-small cell lung cancer (NSCLC) the accurate determination of the lymph node status before therapy is critical to develop an individualized treatment plan. Research from the October issue of the Journal of Nuclear Medicine highlights a new way for this information to be collected -- a virtual fly-through three-dimensional 18F-FDG PET/computed tomography (FDG-PET/CT) bronchoscopy that has high diagnostic accuracy for the detection of regional lymph node metastases.

4 Oct 2011

Interactive video games appear to safely enhance physical therapy for ICU patients

Interactive video games, already known to improve motor function in recovering stroke patients, appear to safely enhance physical therapy for patients in intensive care units (ICU), new research from Johns Hopkins suggests.

4 Oct 2011

Microscopy with helium ions may greatly enhance both surface and sub-cellular imaging

The ability to obtain an accurate three-dimensional image of an intact cell is critical for unraveling the mysteries of cellular structure and function. However, for many years, tiny structures buried deep inside cells have been practically invisible to scientists due to a lack of microscopic techniques that achieve adequate resolution at the cell surface and through the entire depth of the cell.

4 Oct 2011

CDRH report highlights scientific activities that support medical device industry

The U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) today released a report highlighting scientific activities that support the medical device industry and product development, while maintaining the safety and effectiveness of the products.

4 Oct 2011

MR-guided focused ultrasound may effectively control essential tremor

In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10 million Americans.

4 Oct 2011

Researchers apply new approach to take a close look at amyloid plaque formation

Researchers at the University of Toronto Scarborough (UTSC) and Osaka University applied a new approach to take a close look at amyloid plaque formation, a process that plays important roles in Alzheimer's disease.

4 Oct 2011

Cancer patients prefer to use Web-based technology for quality of life survey

When cancer patients are given the choice, they are significantly more likely to use Web-based technology to answer questions about their quality of life six months after treatment, compared to a paper survey, according to a unique study presented at a scientific session, October 5, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.

4 Oct 2011

TAU researcher implants robotic cerebellum to repair motor function

With new cutting-edge technology aimed at providing amputees with robotic limbs, a Tel Aviv University researcher has successfully implanted a robotic cerebellum into the skull of a rodent with brain damage, restoring its capacity for movement.

4 Oct 2011

Largest prospective study of MRI in patients with implanted devices

Magnetic Resonance Imaging (MRI), an important diagnostic test, has traditionally been off limits to more than 2 million people in the United States who have an implanted pacemaker to regulate heart rhythms or an implanted defibrillator to prevent sudden cardiac death.

4 Oct 2011

Scientists develop first polymeric material that is sensitive to very low levels of NIR irradiation

Scientists at the University of California, San Diego have developed what they believe to be the first polymeric material that is sensitive to biologically benign levels of near infrared (NIR) irradiation, enabling the material to disassemble in a highly controlled fashion.

4 Oct 2011

TriLogic, Mission Pharmacal partner to develop new drug delivery system

Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.

4 Oct 2011